InspireMD (NSPR) Assets Growth (3y) (2013 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | InspireMD | 64.01 Mn | 9.80 Mn | 1.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 41.20% |
| Sep 30, 2025 | 40.89% |
| Jun 30, 2025 | 0.58% |
| Mar 31, 2025 | 3.21% |
| Dec 31, 2024 | 5.63% |
| Sep 30, 2024 | 5.82% |
| Jun 30, 2024 | 6.27% |
| Mar 31, 2024 | -4.75% |
| Dec 31, 2023 | 38.90% |
| Sep 30, 2023 | 47.43% |
| Jun 30, 2023 | 44.60% |
| Mar 31, 2023 | 39.20% |
| Dec 31, 2022 | 35.63% |
| Sep 30, 2022 | 34.16% |
| Jun 30, 2022 | 52.25% |
| Mar 31, 2022 | 51.79% |
| Dec 31, 2021 | 47.85% |
| Sep 30, 2021 | 45.15% |
| Jun 30, 2021 | 69.81% |
| Mar 31, 2021 | 88.30% |
| Dec 31, 2020 | 42.78% |
| Sep 30, 2020 | 29.95% |
| Jun 30, 2020 | 25.82% |
| Mar 31, 2020 | -11.10% |
| Dec 31, 2019 | 1.64% |
| Sep 30, 2019 | -2.29% |
| Jun 30, 2019 | 45.40% |
| Dec 31, 2018 | 29.23% |
| Jun 30, 2018 | -11.28% |
| Dec 31, 2017 | -18.92% |
| Jun 30, 2017 | -13.91% |
| Mar 31, 2017 | -18.62% |
| Dec 31, 2016 | -26.77% |
| Sep 30, 2016 | -11.03% |
| Jun 30, 2016 | -47.39% |
| Dec 31, 2015 | -21.11% |
| Jun 30, 2015 | -5.39% |
| Dec 31, 2014 | 3.07% |
| Jun 30, 2014 | 7.16% |
| Dec 31, 2013 | 76.55% |